Skip to main content
. 2021 Jun 24;336:252–261. doi: 10.1016/j.jconrel.2021.06.033

Fig. 6.

Fig. 6

LEAF-4L6715 efficiently improved the oxygenation of COVID-19 patients in cohort 1 and 2 (n = 6/group). (A) Validation of the major endpoint criteria of the study, including PaO2/FiO2 ratio, PEP, PaCO2, noradrenaline status, and position of the patients 3 days before and 3 days after the first injection of LEAF-4L6715. (B) Mean adjusted SOFA score along with cardiovascular and respiratory SOFA subscores. All data are presented as the mean ± standard error of the mean. The adjusted SOFA score excludes the liver biology to avoid the interference with the AE related to the LEAF-4L6715 exposure. Wilcoxon tests were performed to compare the different increase of PaO2/FiO2 within the same group and the SOFA scores evolutions. **p-value<0.01.